Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials

Citation
Marsico F, Paolillo S, Gargiulo P, et al. Eur Heart J 2020; epub ahead of press.